

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 4.96642617 |
| 2 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.91965622 |
| 3 | vocalization behavior (GO:0071625) | 4.75067886 |
| 4 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.36448592 |
| 5 | synaptic vesicle exocytosis (GO:0016079) | 4.35995053 |
| 6 | neuron cell-cell adhesion (GO:0007158) | 4.30874939 |
| 7 | glutamate secretion (GO:0014047) | 4.27901681 |
| 8 | cilium or flagellum-dependent cell motility (GO:0001539) | 4.27727961 |
| 9 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.23812067 |
| 10 | monoubiquitinated protein deubiquitination (GO:0035520) | 4.20517941 |
| 11 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.20130841 |
| 12 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.13868326 |
| 13 | protein K11-linked deubiquitination (GO:0035871) | 4.12848866 |
| 14 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.12195092 |
| 15 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 4.04355212 |
| 16 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.03747348 |
| 17 | glutamate receptor signaling pathway (GO:0007215) | 3.97272609 |
| 18 | interkinetic nuclear migration (GO:0022027) | 3.96536674 |
| 19 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.95793324 |
| 20 | protein localization to synapse (GO:0035418) | 3.94447864 |
| 21 | presynaptic membrane assembly (GO:0097105) | 3.92901830 |
| 22 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.89266629 |
| 23 | regulation of synaptic vesicle transport (GO:1902803) | 3.87252545 |
| 24 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 3.84499511 |
| 25 | regulation of translation, ncRNA-mediated (GO:0045974) | 3.84499511 |
| 26 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 3.84499511 |
| 27 | synaptic vesicle maturation (GO:0016188) | 3.82027978 |
| 28 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 3.80456926 |
| 29 | neuron-neuron synaptic transmission (GO:0007270) | 3.75895082 |
| 30 | histone H3-K4 trimethylation (GO:0080182) | 3.71386845 |
| 31 | centriole replication (GO:0007099) | 3.69615538 |
| 32 | neuronal action potential propagation (GO:0019227) | 3.67956153 |
| 33 | synaptic transmission, glutamatergic (GO:0035249) | 3.67146564 |
| 34 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.65770945 |
| 35 | retinal cone cell development (GO:0046549) | 3.63630717 |
| 36 | neurotransmitter secretion (GO:0007269) | 3.58125786 |
| 37 | epithelial cilium movement (GO:0003351) | 3.53025970 |
| 38 | cilium movement (GO:0003341) | 3.51291127 |
| 39 | detection of light stimulus involved in visual perception (GO:0050908) | 3.50535156 |
| 40 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.50535156 |
| 41 | rRNA catabolic process (GO:0016075) | 3.50529211 |
| 42 | neuron recognition (GO:0008038) | 3.49959568 |
| 43 | long-term synaptic potentiation (GO:0060291) | 3.47407863 |
| 44 | presynaptic membrane organization (GO:0097090) | 3.47158187 |
| 45 | startle response (GO:0001964) | 3.45684420 |
| 46 | locomotory exploration behavior (GO:0035641) | 3.44920845 |
| 47 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.43273651 |
| 48 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.43033846 |
| 49 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.43022967 |
| 50 | * protein localization to Golgi apparatus (GO:0034067) | 3.42635295 |
| 51 | synaptic vesicle endocytosis (GO:0048488) | 3.42368396 |
| 52 | neural tube formation (GO:0001841) | 3.41792558 |
| 53 | regulation of establishment of cell polarity (GO:2000114) | 3.34873591 |
| 54 | protein K63-linked deubiquitination (GO:0070536) | 3.32897821 |
| 55 | response to histamine (GO:0034776) | 3.32635053 |
| 56 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.32394151 |
| 57 | gamma-aminobutyric acid transport (GO:0015812) | 3.31287292 |
| 58 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.31166150 |
| 59 | * protein targeting to Golgi (GO:0000042) | 3.31045890 |
| 60 | regulation of postsynaptic membrane potential (GO:0060078) | 3.30974207 |
| 61 | detection of calcium ion (GO:0005513) | 3.26330425 |
| 62 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.25119843 |
| 63 | long-term memory (GO:0007616) | 3.21060702 |
| 64 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.18477406 |
| 65 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.15840151 |
| 66 | axonal fasciculation (GO:0007413) | 3.14673775 |
| 67 | axoneme assembly (GO:0035082) | 3.14608126 |
| 68 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213) | 3.12380925 |
| 69 | regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211) | 3.12380925 |
| 70 | histone mRNA catabolic process (GO:0071044) | 3.09837845 |
| 71 | neurotransmitter transport (GO:0006836) | 3.09570677 |
| 72 | negative regulation of neurotransmitter transport (GO:0051589) | 3.08271276 |
| 73 | transmission of nerve impulse (GO:0019226) | 3.08147813 |
| 74 | regulation of cilium movement (GO:0003352) | 3.07650839 |
| 75 | proline transport (GO:0015824) | 3.06284495 |
| 76 | postsynaptic membrane organization (GO:0001941) | 3.06179872 |
| 77 | prenylation (GO:0097354) | 3.06019536 |
| 78 | protein prenylation (GO:0018342) | 3.06019536 |
| 79 | regulation of synaptic plasticity (GO:0048167) | 3.05341290 |
| 80 | dendritic spine morphogenesis (GO:0060997) | 3.04055030 |
| 81 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.03921826 |
| 82 | exploration behavior (GO:0035640) | 3.03394446 |
| 83 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151) | 3.03136519 |
| 84 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO | 3.03136519 |
| 85 | regulation of establishment or maintenance of cell polarity (GO:0032878) | 3.02866946 |
| 86 | innervation (GO:0060384) | 3.00938314 |
| 87 | positive regulation of mRNA catabolic process (GO:0061014) | 3.00721626 |
| 88 | protein K48-linked deubiquitination (GO:0071108) | 2.98226584 |
| 89 | * retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.97525819 |
| 90 | female mating behavior (GO:0060180) | 2.96724451 |
| 91 | regulation of female receptivity (GO:0045924) | 2.96404912 |
| 92 | fucose catabolic process (GO:0019317) | 2.95616043 |
| 93 | L-fucose metabolic process (GO:0042354) | 2.95616043 |
| 94 | L-fucose catabolic process (GO:0042355) | 2.95616043 |
| 95 | Golgi to endosome transport (GO:0006895) | 2.95465932 |
| 96 | negative regulation of dendrite development (GO:2000171) | 2.95352781 |
| 97 | peptidyl-lysine trimethylation (GO:0018023) | 2.94787202 |
| 98 | long term synaptic depression (GO:0060292) | 2.94581655 |
| 99 | vesicle transport along microtubule (GO:0047496) | 2.94513485 |
| 100 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.91498195 |
| 101 | regulation of vesicle fusion (GO:0031338) | 2.91191563 |
| 102 | kidney morphogenesis (GO:0060993) | 2.91131036 |
| 103 | serotonin metabolic process (GO:0042428) | 2.90899686 |
| 104 | cochlea development (GO:0090102) | 2.89238761 |
| 105 | histone H3-K9 methylation (GO:0051567) | 2.88656507 |
| 106 | positive regulation of membrane potential (GO:0045838) | 2.88654027 |
| 107 | regulation of neurotransmitter secretion (GO:0046928) | 2.88277435 |
| 108 | synapse assembly (GO:0007416) | 2.87014608 |
| 109 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.84869795 |
| 110 | regulation of glutamate secretion (GO:0014048) | 2.84781716 |
| 111 | * establishment of protein localization to Golgi (GO:0072600) | 2.84760025 |
| 112 | membrane depolarization (GO:0051899) | 2.83664154 |
| 113 | axonemal dynein complex assembly (GO:0070286) | 2.83650200 |
| 114 | centriole assembly (GO:0098534) | 2.83627274 |
| 115 | regulation of neurotransmitter levels (GO:0001505) | 2.83211109 |
| 116 | striatum development (GO:0021756) | 2.82399759 |
| 117 | mechanosensory behavior (GO:0007638) | 2.81547905 |
| 118 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.81453581 |
| 119 | righting reflex (GO:0060013) | 2.79109100 |
| 120 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.77144459 |
| 121 | cyclic nucleotide catabolic process (GO:0009214) | 2.74536976 |
| 122 | behavioral response to cocaine (GO:0048148) | 2.74516603 |
| 123 | protein localization to cilium (GO:0061512) | 2.74084746 |
| 124 | cAMP catabolic process (GO:0006198) | 2.72373688 |
| 125 | cellular potassium ion homeostasis (GO:0030007) | 2.72324499 |
| 126 | regulation of meiosis I (GO:0060631) | 2.71116568 |
| 127 | behavioral fear response (GO:0001662) | 2.70789366 |
| 128 | behavioral defense response (GO:0002209) | 2.70789366 |
| 129 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.70725427 |
| 130 | cilium morphogenesis (GO:0060271) | 2.70375655 |
| 131 | membrane hyperpolarization (GO:0060081) | 2.69585645 |
| 132 | cellular response to ethanol (GO:0071361) | 2.69011655 |
| 133 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 2.66616455 |
| 134 | positive regulation of neurotransmitter transport (GO:0051590) | 2.66452586 |
| 135 | regulation of neurotransmitter transport (GO:0051588) | 2.66311408 |
| 136 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.63569391 |
| 137 | learning (GO:0007612) | 2.63547001 |
| 138 | regulation of exocytosis (GO:0017157) | 2.63458018 |
| 139 | membrane depolarization during action potential (GO:0086010) | 2.63027292 |
| 140 | fear response (GO:0042596) | 2.62981776 |
| 141 | establishment of synaptic vesicle localization (GO:0097480) | 2.62854913 |
| 142 | synaptic vesicle transport (GO:0048489) | 2.62854913 |
| 143 | regulation of DNA endoreduplication (GO:0032875) | 2.61987588 |
| 144 | positive regulation of exocytosis (GO:0045921) | 2.61939615 |
| 145 | dendritic spine organization (GO:0097061) | 2.60847755 |
| 146 | regulation of synapse structural plasticity (GO:0051823) | 2.60265936 |
| 147 | regulation of dendritic spine development (GO:0060998) | 2.58765733 |
| 148 | cilium organization (GO:0044782) | 2.58687101 |
| 149 | sulfation (GO:0051923) | 2.58503612 |
| 150 | establishment of vesicle localization (GO:0051650) | 2.57194245 |
| 151 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.57012311 |
| 152 | cerebellar granule cell differentiation (GO:0021707) | 2.56962403 |
| 153 | lipid translocation (GO:0034204) | 2.56646450 |
| 154 | phospholipid translocation (GO:0045332) | 2.56646450 |
| 155 | synaptic transmission (GO:0007268) | 2.56442802 |
| 156 | serotonin receptor signaling pathway (GO:0007210) | 2.56296411 |
| 157 | regulation of protein glycosylation (GO:0060049) | 2.53458729 |
| 158 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.51884208 |
| 159 | transepithelial transport (GO:0070633) | 2.51430655 |
| 160 | ncRNA catabolic process (GO:0034661) | 2.51249102 |
| 161 | positive regulation of glycolytic process (GO:0045821) | 2.50865812 |
| 162 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.50159935 |
| 163 | intestinal epithelial cell development (GO:0060576) | 2.48606826 |
| 164 | peptidyl-lysine methylation (GO:0018022) | 2.46837223 |
| 165 | photoreceptor cell maintenance (GO:0045494) | 2.46555197 |
| 166 | regulation of mRNA catabolic process (GO:0061013) | 2.46462110 |
| 167 | cilium assembly (GO:0042384) | 2.43706849 |
| 168 | negative T cell selection (GO:0043383) | 2.43506638 |
| 169 | regulation of energy homeostasis (GO:2000505) | 2.43024051 |
| 170 | cellular response to interleukin-15 (GO:0071350) | 2.40602751 |
| 171 | early endosome to late endosome transport (GO:0045022) | 2.35268341 |
| 172 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.34429827 |
| 173 | positive regulation of mRNA metabolic process (GO:1903313) | 2.33149466 |
| 174 | nucleus localization (GO:0051647) | 2.32500696 |
| 175 | retina layer formation (GO:0010842) | 2.31998534 |
| 176 | thyroid hormone metabolic process (GO:0042403) | 2.31763980 |
| 177 | single strand break repair (GO:0000012) | 2.30772210 |
| 178 | peptidyl-threonine dephosphorylation (GO:0035970) | 2.30471722 |
| 179 | interferon-gamma production (GO:0032609) | 2.29907309 |
| 180 | positive regulation of protein autophosphorylation (GO:0031954) | 2.29284185 |
| 181 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 2.28133834 |
| 182 | histone H3-K9 modification (GO:0061647) | 2.27748436 |
| 183 | eye photoreceptor cell development (GO:0042462) | 2.27545977 |
| 184 | photoreceptor cell development (GO:0042461) | 2.27238136 |
| 185 | positive regulation of mRNA processing (GO:0050685) | 2.26693269 |
| 186 | negative thymic T cell selection (GO:0045060) | 2.25831610 |
| 187 | tonic smooth muscle contraction (GO:0014820) | 2.25362365 |
| 188 | vascular smooth muscle contraction (GO:0014829) | 2.25299555 |
| 189 | regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095) | 2.23901832 |
| 190 | histone-serine phosphorylation (GO:0035404) | 2.22847366 |
| 191 | signal peptide processing (GO:0006465) | 2.22832676 |
| 192 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.22593498 |
| 193 | positive regulation of granulocyte differentiation (GO:0030854) | 2.21617641 |
| 194 | artery smooth muscle contraction (GO:0014824) | 2.21155969 |
| 195 | regulation of gene silencing by miRNA (GO:0060964) | 2.20643733 |
| 196 | regulation of gene silencing by RNA (GO:0060966) | 2.20643733 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.31882313 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.89658394 |
| 3 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.57456063 |
| 4 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.52052471 |
| 5 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.33619232 |
| 6 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.29119093 |
| 7 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.21893119 |
| 8 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.21040207 |
| 9 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.20173410 |
| 10 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.18907376 |
| 11 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.17806618 |
| 12 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 2.16541543 |
| 13 | SMAD4_21799915_ChIP-Seq_A2780_Human | 2.11794399 |
| 14 | FUS_26573619_Chip-Seq_HEK293_Human | 2.08885096 |
| 15 | P300_19829295_ChIP-Seq_ESCs_Human | 2.06862926 |
| 16 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.06109737 |
| 17 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.02188491 |
| 18 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.00749714 |
| 19 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.95910720 |
| 20 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.94632903 |
| 21 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.90968636 |
| 22 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.88051656 |
| 23 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.85364372 |
| 24 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.84662912 |
| 25 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.79413976 |
| 26 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.78292383 |
| 27 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.78137231 |
| 28 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.75315432 |
| 29 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.73977853 |
| 30 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.70880246 |
| 31 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.70642657 |
| 32 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.69970719 |
| 33 | STAT3_23295773_ChIP-Seq_U87_Human | 1.69563024 |
| 34 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.66714644 |
| 35 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.65769636 |
| 36 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.64952213 |
| 37 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.64926351 |
| 38 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.64895674 |
| 39 | AR_25329375_ChIP-Seq_VCAP_Human | 1.63104049 |
| 40 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.61925551 |
| 41 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.61601443 |
| 42 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.61533298 |
| 43 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.60955676 |
| 44 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.60000551 |
| 45 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.59178999 |
| 46 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.57221438 |
| 47 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.57221438 |
| 48 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.56663818 |
| 49 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.55510511 |
| 50 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.55429949 |
| 51 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.54556810 |
| 52 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.54122084 |
| 53 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.52839857 |
| 54 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.52303154 |
| 55 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.50943758 |
| 56 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.49293661 |
| 57 | * TP53_16413492_ChIP-PET_HCT116_Human | 1.49090860 |
| 58 | TCF4_23295773_ChIP-Seq_U87_Human | 1.48460387 |
| 59 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.46547137 |
| 60 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.46155642 |
| 61 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.46065828 |
| 62 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.45387022 |
| 63 | EWS_26573619_Chip-Seq_HEK293_Human | 1.42788285 |
| 64 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.42461825 |
| 65 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.42454766 |
| 66 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.42408269 |
| 67 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.41986761 |
| 68 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.41431985 |
| 69 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.39233118 |
| 70 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.37955764 |
| 71 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.37897226 |
| 72 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.37585162 |
| 73 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.37122114 |
| 74 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.35961052 |
| 75 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.35092480 |
| 76 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.34142443 |
| 77 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.33691819 |
| 78 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.32616261 |
| 79 | * CDX2_22108803_ChIP-Seq_LS180_Human | 1.31612319 |
| 80 | VDR_22108803_ChIP-Seq_LS180_Human | 1.31417416 |
| 81 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.30481993 |
| 82 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.28957075 |
| 83 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.28957075 |
| 84 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.28754863 |
| 85 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.28524642 |
| 86 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.28333293 |
| 87 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.27463431 |
| 88 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.27296408 |
| 89 | * CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.26321682 |
| 90 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.24738963 |
| 91 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.23862826 |
| 92 | * FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.23189327 |
| 93 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.21060034 |
| 94 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.21060034 |
| 95 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.20975663 |
| 96 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.20975663 |
| 97 | * OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.20390582 |
| 98 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.19228127 |
| 99 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.18875923 |
| 100 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.17718765 |
| 101 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.17543571 |
| 102 | * SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.16065634 |
| 103 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.15053951 |
| 104 | KDM2B_26808549_Chip-Seq_REH_Human | 1.14817138 |
| 105 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.14487801 |
| 106 | JUN_21703547_ChIP-Seq_K562_Human | 1.14199180 |
| 107 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.13012872 |
| 108 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.11914271 |
| 109 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.11911439 |
| 110 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.11619767 |
| 111 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.11527228 |
| 112 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.11419984 |
| 113 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.10773930 |
| 114 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.10761079 |
| 115 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.10541267 |
| 116 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.10541267 |
| 117 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.10532065 |
| 118 | * TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.10300294 |
| 119 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.09946874 |
| 120 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.09831058 |
| 121 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.08751636 |
| 122 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.08522740 |
| 123 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.07816490 |
| 124 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.07220022 |
| 125 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.03560584 |
| 126 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.03531308 |
| 127 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.01002749 |
| 128 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.00716896 |
| 129 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.99542364 |
| 130 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.98809353 |
| 131 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.97733328 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 4.91630398 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 4.87964834 |
| 3 | MP0008057_abnormal_DNA_replication | 3.61877970 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 3.52739329 |
| 5 | MP0003195_calcinosis | 3.40326776 |
| 6 | MP0009780_abnormal_chondrocyte_physiolo | 3.36087840 |
| 7 | MP0004270_analgesia | 3.36048975 |
| 8 | MP0009745_abnormal_behavioral_response | 3.18648207 |
| 9 | MP0003787_abnormal_imprinting | 3.14194232 |
| 10 | MP0002063_abnormal_learning/memory/cond | 2.96441089 |
| 11 | MP0001968_abnormal_touch/_nociception | 2.82557348 |
| 12 | MP0002572_abnormal_emotion/affect_behav | 2.72918775 |
| 13 | MP0002064_seizures | 2.67463557 |
| 14 | MP0009046_muscle_twitch | 2.61284495 |
| 15 | MP0002736_abnormal_nociception_after | 2.49838753 |
| 16 | MP0002734_abnormal_mechanical_nocicepti | 2.44642280 |
| 17 | MP0001501_abnormal_sleep_pattern | 2.36888617 |
| 18 | MP0002272_abnormal_nervous_system | 2.34651369 |
| 19 | MP0001188_hyperpigmentation | 2.32628357 |
| 20 | MP0001486_abnormal_startle_reflex | 2.23707381 |
| 21 | MP0005646_abnormal_pituitary_gland | 2.20547430 |
| 22 | MP0001440_abnormal_grooming_behavior | 2.09444943 |
| 23 | MP0010386_abnormal_urinary_bladder | 2.06888789 |
| 24 | MP0000569_abnormal_digit_pigmentation | 2.03886022 |
| 25 | MP0006276_abnormal_autonomic_nervous | 1.91542985 |
| 26 | MP0002822_catalepsy | 1.88272359 |
| 27 | MP0002067_abnormal_sensory_capabilities | 1.86805358 |
| 28 | MP0002735_abnormal_chemical_nociception | 1.83222487 |
| 29 | MP0002909_abnormal_adrenal_gland | 1.80702408 |
| 30 | MP0004924_abnormal_behavior | 1.78674246 |
| 31 | MP0005386_behavior/neurological_phenoty | 1.78674246 |
| 32 | MP0008875_abnormal_xenobiotic_pharmacok | 1.78209751 |
| 33 | MP0002166_altered_tumor_susceptibility | 1.70727844 |
| 34 | MP0002557_abnormal_social/conspecific_i | 1.70487560 |
| 35 | MP0000778_abnormal_nervous_system | 1.67854940 |
| 36 | MP0001529_abnormal_vocalization | 1.63807526 |
| 37 | MP0010234_abnormal_vibrissa_follicle | 1.58540928 |
| 38 | MP0001970_abnormal_pain_threshold | 1.58466917 |
| 39 | MP0002876_abnormal_thyroid_physiology | 1.54883661 |
| 40 | MP0003183_abnormal_peptide_metabolism | 1.53945606 |
| 41 | MP0002733_abnormal_thermal_nociception | 1.50857115 |
| 42 | MP0005379_endocrine/exocrine_gland_phen | 1.49762710 |
| 43 | MP0005645_abnormal_hypothalamus_physiol | 1.48309398 |
| 44 | MP0005409_darkened_coat_color | 1.46361996 |
| 45 | MP0003122_maternal_imprinting | 1.43823938 |
| 46 | MP0005085_abnormal_gallbladder_physiolo | 1.43167575 |
| 47 | MP0005423_abnormal_somatic_nervous | 1.41494471 |
| 48 | MP0003866_abnormal_defecation | 1.40416180 |
| 49 | MP0001905_abnormal_dopamine_level | 1.40017519 |
| 50 | MP0002184_abnormal_innervation | 1.38286055 |
| 51 | MP0003763_abnormal_thymus_physiology | 1.37696499 |
| 52 | MP0003633_abnormal_nervous_system | 1.35409126 |
| 53 | MP0000013_abnormal_adipose_tissue | 1.34408701 |
| 54 | MP0001984_abnormal_olfaction | 1.33813183 |
| 55 | MP0000427_abnormal_hair_cycle | 1.33488886 |
| 56 | MP0002837_dystrophic_cardiac_calcinosis | 1.32940726 |
| 57 | MP0005171_absent_coat_pigmentation | 1.31511296 |
| 58 | MP0004885_abnormal_endolymph | 1.27466869 |
| 59 | MP0008569_lethality_at_weaning | 1.25128841 |
| 60 | MP0001666_abnormal_nutrient_absorption | 1.24822790 |
| 61 | MP0009697_abnormal_copulation | 1.23482880 |
| 62 | MP0005551_abnormal_eye_electrophysiolog | 1.22010562 |
| 63 | MP0006072_abnormal_retinal_apoptosis | 1.21920309 |
| 64 | MP0001177_atelectasis | 1.19547092 |
| 65 | MP0004215_abnormal_myocardial_fiber | 1.19093671 |
| 66 | MP0004811_abnormal_neuron_physiology | 1.17950065 |
| 67 | MP0003879_abnormal_hair_cell | 1.16036623 |
| 68 | MP0001502_abnormal_circadian_rhythm | 1.15557162 |
| 69 | MP0002168_other_aberrant_phenotype | 1.13903763 |
| 70 | MP0003631_nervous_system_phenotype | 1.13838983 |
| 71 | MP0002006_tumorigenesis | 1.12041866 |
| 72 | MP0000955_abnormal_spinal_cord | 1.11682974 |
| 73 | MP0005389_reproductive_system_phenotype | 1.11630589 |
| 74 | MP0005174_abnormal_tail_pigmentation | 1.11399166 |
| 75 | MP0002102_abnormal_ear_morphology | 1.11237950 |
| 76 | MP0005253_abnormal_eye_physiology | 1.09827891 |
| 77 | MP0010678_abnormal_skin_adnexa | 1.09180474 |
| 78 | MP0002160_abnormal_reproductive_system | 1.08803228 |
| 79 | MP0002066_abnormal_motor_capabilities/c | 1.08736441 |
| 80 | MP0000383_abnormal_hair_follicle | 1.08672026 |
| 81 | MP0008877_abnormal_DNA_methylation | 1.08390714 |
| 82 | MP0003329_amyloid_beta_deposits | 1.06575898 |
| 83 | MP0004134_abnormal_chest_morphology | 1.05406991 |
| 84 | MP0002882_abnormal_neuron_morphology | 1.05029995 |
| 85 | MP0004484_altered_response_of | 1.04579116 |
| 86 | MP0004043_abnormal_pH_regulation | 1.03953525 |
| 87 | MP0004147_increased_porphyrin_level | 1.03065062 |
| 88 | MP0001664_abnormal_digestion | 1.02124249 |
| 89 | MP0001919_abnormal_reproductive_system | 1.02038729 |
| 90 | MP0005075_abnormal_melanosome_morpholog | 1.00943548 |
| 91 | MP0010352_gastrointestinal_tract_polyps | 0.99825985 |
| 92 | MP0005395_other_phenotype | 0.97684856 |
| 93 | MP0003121_genomic_imprinting | 0.96041550 |
| 94 | MP0008872_abnormal_physiological_respon | 0.95161380 |
| 95 | MP0002229_neurodegeneration | 0.94792616 |
| 96 | MP0002396_abnormal_hematopoietic_system | 0.94230549 |
| 97 | MP0005535_abnormal_body_temperature | 0.93768990 |
| 98 | MP0005084_abnormal_gallbladder_morpholo | 0.93404071 |
| 99 | MP0005671_abnormal_response_to | 0.93214754 |
| 100 | MP0003718_maternal_effect | 0.91713902 |
| 101 | MP0002138_abnormal_hepatobiliary_system | 0.90628418 |
| 102 | MP0001963_abnormal_hearing_physiology | 0.85359016 |
| 103 | MP0003724_increased_susceptibility_to | 0.85295259 |
| 104 | MP0005360_urolithiasis | 0.85103342 |
| 105 | MP0002152_abnormal_brain_morphology | 0.83902080 |
| 106 | MP0001929_abnormal_gametogenesis | 0.81946415 |
| 107 | MP0003690_abnormal_glial_cell | 0.81327747 |
| 108 | MP0004742_abnormal_vestibular_system | 0.80853354 |
| 109 | MP0005636_abnormal_mineral_homeostasis | 0.80509924 |
| 110 | MP0000631_abnormal_neuroendocrine_gland | 0.80050034 |
| 111 | MP0003119_abnormal_digestive_system | 0.79305670 |
| 112 | MP0002928_abnormal_bile_duct | 0.78893687 |
| 113 | MP0002069_abnormal_eating/drinking_beha | 0.77835762 |
| 114 | MP0005167_abnormal_blood-brain_barrier | 0.77509455 |
| 115 | MP0003632_abnormal_nervous_system | 0.77069772 |
| 116 | MP0001800_abnormal_humoral_immune | 0.74777585 |
| 117 | MP0001485_abnormal_pinna_reflex | 0.74664413 |
| 118 | MP0003890_abnormal_embryonic-extraembry | 0.74160176 |
| 119 | MP0010329_abnormal_lipoprotein_level | 0.72686533 |
| 120 | MP0003252_abnormal_bile_duct | 0.72212855 |
| 121 | MP0002638_abnormal_pupillary_reflex | 0.71429627 |
| 122 | MP0003283_abnormal_digestive_organ | 0.71345004 |
| 123 | MP0000653_abnormal_sex_gland | 0.71117070 |
| 124 | MP0004145_abnormal_muscle_electrophysio | 0.70486597 |
| 125 | MP0003698_abnormal_male_reproductive | 0.70233343 |
| 126 | MP0004264_abnormal_extraembryonic_tissu | 0.69437852 |
| 127 | MP0002127_abnormal_cardiovascular_syste | 0.67579781 |
| 128 | MP0003045_fibrosis | 0.67560208 |
| 129 | MP0001765_abnormal_ion_homeostasis | 0.66959812 |
| 130 | MP0005410_abnormal_fertilization | 0.66874976 |
| 131 | MP0000703_abnormal_thymus_morphology | 0.66373616 |
| 132 | MP0003868_abnormal_feces_composition | 0.66256921 |
| 133 | MP0005187_abnormal_penis_morphology | 0.66254649 |
| 134 | MP0002009_preneoplasia | 0.66226370 |
| 135 | MP0006292_abnormal_olfactory_placode | 0.65512037 |
| 136 | MP0005647_abnormal_sex_gland | 0.65459335 |
| 137 | MP0008058_abnormal_DNA_repair | 0.65330924 |
| 138 | MP0005220_abnormal_exocrine_pancreas | 0.65011825 |
| 139 | MP0003567_abnormal_fetal_cardiomyocyte | 0.64808748 |
| 140 | MP0000470_abnormal_stomach_morphology | 0.64309205 |
| 141 | MP0004142_abnormal_muscle_tone | 0.63574669 |
| 142 | MP0000538_abnormal_urinary_bladder | 0.63549283 |
| 143 | MP0002693_abnormal_pancreas_physiology | 0.62744422 |
| 144 | MP0000015_abnormal_ear_pigmentation | 0.62141601 |
| 145 | MP0005310_abnormal_salivary_gland | 0.61998867 |
| 146 | MP0004085_abnormal_heartbeat | 0.61990505 |
| 147 | MP0001986_abnormal_taste_sensitivity | 0.61331186 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 6.80779730 |
| 2 | Hyperventilation (HP:0002883) | 4.98657913 |
| 3 | Atonic seizures (HP:0010819) | 4.89303016 |
| 4 | Febrile seizures (HP:0002373) | 4.50975788 |
| 5 | Epileptic encephalopathy (HP:0200134) | 4.49891854 |
| 6 | Focal seizures (HP:0007359) | 4.45063587 |
| 7 | Absence seizures (HP:0002121) | 4.08315157 |
| 8 | Progressive cerebellar ataxia (HP:0002073) | 3.95921803 |
| 9 | Fair hair (HP:0002286) | 3.86330545 |
| 10 | Abnormality of the renal cortex (HP:0011035) | 3.71488253 |
| 11 | Visual hallucinations (HP:0002367) | 3.69175682 |
| 12 | Generalized hypopigmentation of hair (HP:0011358) | 3.63507289 |
| 13 | Myokymia (HP:0002411) | 3.61030853 |
| 14 | Pancreatic cysts (HP:0001737) | 3.59703902 |
| 15 | Renal cortical cysts (HP:0000803) | 3.52441613 |
| 16 | Dialeptic seizures (HP:0011146) | 3.50558101 |
| 17 | Abnormal hair whorl (HP:0010721) | 3.44623805 |
| 18 | Excessive salivation (HP:0003781) | 3.43548149 |
| 19 | Drooling (HP:0002307) | 3.43548149 |
| 20 | Pancreatic fibrosis (HP:0100732) | 3.40680050 |
| 21 | Broad-based gait (HP:0002136) | 3.36998767 |
| 22 | Generalized tonic-clonic seizures (HP:0002069) | 3.35705791 |
| 23 | Gaze-evoked nystagmus (HP:0000640) | 3.34249968 |
| 24 | Protruding tongue (HP:0010808) | 3.22902126 |
| 25 | Stomach cancer (HP:0012126) | 3.15848678 |
| 26 | True hermaphroditism (HP:0010459) | 3.10514954 |
| 27 | Blue irides (HP:0000635) | 3.01823828 |
| 28 | Abnormality of the renal medulla (HP:0100957) | 2.91812824 |
| 29 | Epileptiform EEG discharges (HP:0011182) | 2.91181536 |
| 30 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.90599869 |
| 31 | Abnormality of midbrain morphology (HP:0002418) | 2.88472131 |
| 32 | Molar tooth sign on MRI (HP:0002419) | 2.88472131 |
| 33 | Medial flaring of the eyebrow (HP:0010747) | 2.86907969 |
| 34 | Nephronophthisis (HP:0000090) | 2.83085651 |
| 35 | Truncal ataxia (HP:0002078) | 2.81396999 |
| 36 | Papillary thyroid carcinoma (HP:0002895) | 2.79219867 |
| 37 | T lymphocytopenia (HP:0005403) | 2.78678617 |
| 38 | Scanning speech (HP:0002168) | 2.76879648 |
| 39 | Gait imbalance (HP:0002141) | 2.74583123 |
| 40 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.74041520 |
| 41 | Genetic anticipation (HP:0003743) | 2.72455684 |
| 42 | Rhinitis (HP:0012384) | 2.67202791 |
| 43 | EEG with generalized epileptiform discharges (HP:0011198) | 2.66358402 |
| 44 | Abnormality of T cell number (HP:0011839) | 2.65541407 |
| 45 | Dysmetria (HP:0001310) | 2.60033225 |
| 46 | Abnormality of salivation (HP:0100755) | 2.57569999 |
| 47 | Insidious onset (HP:0003587) | 2.56493112 |
| 48 | Termporal pattern (HP:0011008) | 2.56493112 |
| 49 | Anxiety (HP:0000739) | 2.54218483 |
| 50 | Absent speech (HP:0001344) | 2.52344996 |
| 51 | Bronchiectasis (HP:0002110) | 2.52198410 |
| 52 | Congenital primary aphakia (HP:0007707) | 2.51127300 |
| 53 | Impaired smooth pursuit (HP:0007772) | 2.49815903 |
| 54 | Thyroiditis (HP:0100646) | 2.49589021 |
| 55 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.49160444 |
| 56 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.49160444 |
| 57 | Action tremor (HP:0002345) | 2.48136567 |
| 58 | Dysdiadochokinesis (HP:0002075) | 2.45050532 |
| 59 | Progressive inability to walk (HP:0002505) | 2.44711786 |
| 60 | Inability to walk (HP:0002540) | 2.42519149 |
| 61 | Amblyopia (HP:0000646) | 2.42006411 |
| 62 | Abnormal ciliary motility (HP:0012262) | 2.41193072 |
| 63 | Hypsarrhythmia (HP:0002521) | 2.40154822 |
| 64 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.38183148 |
| 65 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.38183148 |
| 66 | Congenital stationary night blindness (HP:0007642) | 2.36038035 |
| 67 | Volvulus (HP:0002580) | 2.33822174 |
| 68 | Poor coordination (HP:0002370) | 2.33428842 |
| 69 | Nephrogenic diabetes insipidus (HP:0009806) | 2.30943531 |
| 70 | Poor eye contact (HP:0000817) | 2.28744583 |
| 71 | Chronic bronchitis (HP:0004469) | 2.26813591 |
| 72 | Cystic liver disease (HP:0006706) | 2.26561128 |
| 73 | Tubulointerstitial nephritis (HP:0001970) | 2.26080350 |
| 74 | Abnormality of the corticospinal tract (HP:0002492) | 2.24776142 |
| 75 | Clumsiness (HP:0002312) | 2.20878006 |
| 76 | Acanthocytosis (HP:0001927) | 2.19807825 |
| 77 | Widely spaced teeth (HP:0000687) | 2.19480940 |
| 78 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.17601669 |
| 79 | Absent/shortened dynein arms (HP:0200106) | 2.17601669 |
| 80 | Cerebral inclusion bodies (HP:0100314) | 2.17529556 |
| 81 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.17285401 |
| 82 | Bronchitis (HP:0012387) | 2.15011414 |
| 83 | Exotropia (HP:0000577) | 2.12799532 |
| 84 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.11303487 |
| 85 | Agitation (HP:0000713) | 2.09508742 |
| 86 | Inappropriate behavior (HP:0000719) | 2.08389661 |
| 87 | Abnormality of binocular vision (HP:0011514) | 2.07888547 |
| 88 | Diplopia (HP:0000651) | 2.07888547 |
| 89 | Gonadotropin excess (HP:0000837) | 2.07819873 |
| 90 | Abnormality of the nasal septum (HP:0000419) | 2.07753567 |
| 91 | Metabolic alkalosis (HP:0200114) | 2.07638367 |
| 92 | Recurrent bronchitis (HP:0002837) | 2.06897418 |
| 93 | Attenuation of retinal blood vessels (HP:0007843) | 2.06784272 |
| 94 | Impaired vibratory sensation (HP:0002495) | 2.06196050 |
| 95 | Supranuclear gaze palsy (HP:0000605) | 2.06100511 |
| 96 | Impaired social interactions (HP:0000735) | 2.04314128 |
| 97 | Abnormal social behavior (HP:0012433) | 2.04314128 |
| 98 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.04109211 |
| 99 | Pheochromocytoma (HP:0002666) | 2.01438952 |
| 100 | Postural instability (HP:0002172) | 2.01077553 |
| 101 | Tubular atrophy (HP:0000092) | 2.01053393 |
| 102 | Thyroid carcinoma (HP:0002890) | 1.99221942 |
| 103 | Genital tract atresia (HP:0001827) | 1.98839215 |
| 104 | Abnormal biliary tract morphology (HP:0012440) | 1.97269297 |
| 105 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.95938723 |
| 106 | Male pseudohermaphroditism (HP:0000037) | 1.95574324 |
| 107 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.94873217 |
| 108 | Conjugated hyperbilirubinemia (HP:0002908) | 1.94411137 |
| 109 | IgG deficiency (HP:0004315) | 1.94080119 |
| 110 | Abnormality of macular pigmentation (HP:0008002) | 1.92906020 |
| 111 | Postaxial foot polydactyly (HP:0001830) | 1.92309863 |
| 112 | Lower limb muscle weakness (HP:0007340) | 1.92210695 |
| 113 | Hyperthyroidism (HP:0000836) | 1.91094116 |
| 114 | Median cleft lip (HP:0000161) | 1.91051276 |
| 115 | Decreased circulating renin level (HP:0003351) | 1.90649652 |
| 116 | Generalized myoclonic seizures (HP:0002123) | 1.90473332 |
| 117 | Spastic gait (HP:0002064) | 1.88750649 |
| 118 | Biliary tract neoplasm (HP:0100574) | 1.88360010 |
| 119 | Decreased central vision (HP:0007663) | 1.87780381 |
| 120 | Vaginal atresia (HP:0000148) | 1.87582434 |
| 121 | Abolished electroretinogram (ERG) (HP:0000550) | 1.87459147 |
| 122 | Stereotypic behavior (HP:0000733) | 1.86656886 |
| 123 | Chronic hepatic failure (HP:0100626) | 1.86424289 |
| 124 | Papilledema (HP:0001085) | 1.86038123 |
| 125 | Gait ataxia (HP:0002066) | 1.84928853 |
| 126 | Abnormal pancreas size (HP:0012094) | 1.84856759 |
| 127 | Metaphyseal dysplasia (HP:0100255) | 1.84535179 |
| 128 | Abnormality of chromosome stability (HP:0003220) | 1.84312901 |
| 129 | Supernumerary spleens (HP:0009799) | 1.84121142 |
| 130 | Abnormality of renin-angiotensin system (HP:0000847) | 1.84108325 |
| 131 | Gastroesophageal reflux (HP:0002020) | 1.83861170 |
| 132 | Congenital hepatic fibrosis (HP:0002612) | 1.82888469 |
| 133 | Autoimmune hemolytic anemia (HP:0001890) | 1.82227476 |
| 134 | Enlarged kidneys (HP:0000105) | 1.81383169 |
| 135 | Thickened helices (HP:0000391) | 1.81166378 |
| 136 | Hypothermia (HP:0002045) | 1.80565179 |
| 137 | Polydipsia (HP:0001959) | 1.79410959 |
| 138 | Abnormal drinking behavior (HP:0030082) | 1.79410959 |
| 139 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.79316938 |
| 140 | Neuroendocrine neoplasm (HP:0100634) | 1.79233925 |
| 141 | Azoospermia (HP:0000027) | 1.78458689 |
| 142 | Specific learning disability (HP:0001328) | 1.78145245 |
| 143 | Oligodactyly (hands) (HP:0001180) | 1.78114903 |
| 144 | Abnormality of the lower motor neuron (HP:0002366) | 1.75809916 |
| 145 | Aqueductal stenosis (HP:0002410) | 1.75073372 |
| 146 | Hyperkalemia (HP:0002153) | 1.74840507 |
| 147 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.74211974 |
| 148 | Neurofibrillary tangles (HP:0002185) | 1.73909819 |
| 149 | Colon cancer (HP:0003003) | 1.73644032 |
| 150 | Hemiparesis (HP:0001269) | 1.73302835 |
| 151 | Labial hypoplasia (HP:0000066) | 1.73180538 |
| 152 | Urinary urgency (HP:0000012) | 1.72536811 |
| 153 | Acute myeloid leukemia (HP:0004808) | 1.71908627 |
| 154 | Depression (HP:0000716) | 1.71074007 |
| 155 | Progressive macrocephaly (HP:0004481) | 1.70875161 |
| 156 | Furrowed tongue (HP:0000221) | 1.70343001 |
| 157 | Hypokalemic alkalosis (HP:0001949) | 1.67214969 |
| 158 | Central scotoma (HP:0000603) | 1.67154508 |
| 159 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.66410445 |
| 160 | Prostate neoplasm (HP:0100787) | 1.65694814 |
| 161 | Neoplasm of the adrenal cortex (HP:0100641) | 1.65541133 |
| 162 | Abnormality of vitamin B metabolism (HP:0004340) | 1.65465211 |
| 163 | Methylmalonic acidemia (HP:0002912) | 1.65136553 |
| 164 | Postaxial hand polydactyly (HP:0001162) | 1.61981712 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 3.93480057 |
| 2 | EPHA4 | 3.76295928 |
| 3 | CASK | 3.69513541 |
| 4 | ACVR1B | 3.65438184 |
| 5 | FRK | 3.11107819 |
| 6 | MAP3K4 | 3.06832194 |
| 7 | MAP2K7 | 2.91947040 |
| 8 | MAP3K12 | 2.84531549 |
| 9 | PNCK | 2.53005056 |
| 10 | RIPK4 | 2.49818126 |
| 11 | MAP3K9 | 2.26744422 |
| 12 | TXK | 2.13417445 |
| 13 | AKT3 | 2.13331525 |
| 14 | PLK2 | 2.11589659 |
| 15 | MINK1 | 1.74402739 |
| 16 | NUAK1 | 1.71138376 |
| 17 | INSRR | 1.70515712 |
| 18 | DAPK2 | 1.70240746 |
| 19 | MAP3K13 | 1.68528092 |
| 20 | NLK | 1.68523493 |
| 21 | MAP2K4 | 1.64007443 |
| 22 | BMPR1B | 1.58321824 |
| 23 | BMPR2 | 1.55935160 |
| 24 | MAP3K2 | 1.51542314 |
| 25 | MARK1 | 1.50216887 |
| 26 | MKNK2 | 1.46889155 |
| 27 | TEC | 1.46536755 |
| 28 | OXSR1 | 1.46426663 |
| 29 | SGK2 | 1.41878638 |
| 30 | ZAK | 1.37080807 |
| 31 | BRD4 | 1.29794074 |
| 32 | GRK1 | 1.29768871 |
| 33 | FGFR3 | 1.28914528 |
| 34 | BRSK2 | 1.28387908 |
| 35 | TLK1 | 1.22894772 |
| 36 | GRK5 | 1.22504597 |
| 37 | DAPK1 | 1.20864276 |
| 38 | NTRK1 | 1.10922454 |
| 39 | SGK223 | 1.09963058 |
| 40 | SGK494 | 1.09963058 |
| 41 | TNIK | 1.09656378 |
| 42 | CAMK2A | 1.09306816 |
| 43 | CDK5 | 1.08920555 |
| 44 | EPHA3 | 1.07691561 |
| 45 | GRK7 | 1.07353664 |
| 46 | MAP4K2 | 1.05455366 |
| 47 | PTK2B | 1.05398379 |
| 48 | STK38L | 1.03578781 |
| 49 | CAMK2B | 1.03200888 |
| 50 | KSR1 | 1.02148174 |
| 51 | STK39 | 1.01819396 |
| 52 | IRAK1 | 1.01645119 |
| 53 | FES | 1.01376005 |
| 54 | WNK3 | 1.01265361 |
| 55 | LMTK2 | 1.00270208 |
| 56 | PINK1 | 1.00130001 |
| 57 | CAMK1G | 0.98875083 |
| 58 | MAPK13 | 0.98127958 |
| 59 | TAOK3 | 0.98044845 |
| 60 | PRKCG | 0.97460395 |
| 61 | MST4 | 0.96047293 |
| 62 | BCR | 0.90014258 |
| 63 | PASK | 0.89092082 |
| 64 | SGK1 | 0.87456612 |
| 65 | SGK3 | 0.87015011 |
| 66 | JAK1 | 0.86947785 |
| 67 | TRPM7 | 0.86833643 |
| 68 | IKBKE | 0.86829558 |
| 69 | PRKD3 | 0.86474296 |
| 70 | FER | 0.86419777 |
| 71 | PRKCE | 0.83940734 |
| 72 | NEK6 | 0.83768681 |
| 73 | CAMKK1 | 0.83498453 |
| 74 | FGFR2 | 0.83310976 |
| 75 | TRIM28 | 0.79470320 |
| 76 | ITK | 0.78626594 |
| 77 | NTRK2 | 0.78106474 |
| 78 | EIF2AK3 | 0.77855005 |
| 79 | CAMKK2 | 0.74720405 |
| 80 | NME1 | 0.70375934 |
| 81 | MAPK15 | 0.70091692 |
| 82 | DYRK1A | 0.69758613 |
| 83 | MKNK1 | 0.69741411 |
| 84 | YES1 | 0.69610299 |
| 85 | STK3 | 0.66985329 |
| 86 | WNK1 | 0.65892119 |
| 87 | SIK2 | 0.64084681 |
| 88 | MAP2K6 | 0.62352599 |
| 89 | KSR2 | 0.61952075 |
| 90 | PRKCH | 0.61436626 |
| 91 | FGR | 0.61187398 |
| 92 | TNK2 | 0.60788749 |
| 93 | ERBB4 | 0.60672665 |
| 94 | CSNK1G2 | 0.58000089 |
| 95 | PAK3 | 0.56316085 |
| 96 | PIK3CG | 0.55646298 |
| 97 | MAP3K14 | 0.54017188 |
| 98 | PAK6 | 0.53971310 |
| 99 | PRKCQ | 0.53437045 |
| 100 | CHUK | 0.53059045 |
| 101 | DMPK | 0.52308355 |
| 102 | ERBB2 | 0.51465137 |
| 103 | LATS1 | 0.50650344 |
| 104 | MAP3K7 | 0.50521112 |
| 105 | CDK3 | 0.49863666 |
| 106 | SIK3 | 0.49513718 |
| 107 | STK24 | 0.49424914 |
| 108 | PRKAA2 | 0.49045329 |
| 109 | CAMK2D | 0.47671477 |
| 110 | LCK | 0.47315057 |
| 111 | STK38 | 0.47043992 |
| 112 | SYK | 0.46892250 |
| 113 | ARAF | 0.44924883 |
| 114 | CSNK1A1L | 0.44164208 |
| 115 | CAMK1 | 0.43274231 |
| 116 | CSNK1G1 | 0.42762191 |
| 117 | ERBB3 | 0.42649925 |
| 118 | PLK3 | 0.42461526 |
| 119 | TAF1 | 0.42381475 |
| 120 | STK11 | 0.42257088 |
| 121 | PLK4 | 0.42076751 |
| 122 | ATM | 0.41876665 |
| 123 | WNK4 | 0.41845863 |
| 124 | RET | 0.41651311 |
| 125 | CAMK2G | 0.41565912 |
| 126 | MAP3K6 | 0.41017203 |
| 127 | MELK | 0.40974354 |
| 128 | PIK3CA | 0.40821605 |
| 129 | RPS6KA3 | 0.40490816 |
| 130 | PDK1 | 0.40024373 |
| 131 | PRKG1 | 0.39871976 |
| 132 | ADRBK1 | 0.39389406 |
| 133 | CDK19 | 0.38065208 |
| 134 | RAF1 | 0.37680213 |
| 135 | KIT | 0.36848561 |
| 136 | MAP4K1 | 0.36636691 |
| 137 | PDK3 | 0.35395130 |
| 138 | PDK4 | 0.35395130 |
| 139 | PDPK1 | 0.35109681 |
| 140 | IGF1R | 0.34704601 |
| 141 | CSNK1D | 0.34216884 |
| 142 | CSNK1E | 0.34193316 |
| 143 | PRKCB | 0.33760460 |
| 144 | FYN | 0.32911502 |
| 145 | PRKCA | 0.32718804 |
| 146 | TIE1 | 0.32586910 |
| 147 | ROCK2 | 0.32347694 |
| 148 | ADRBK2 | 0.32063102 |
| 149 | MAPK10 | 0.31535025 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.89671562 |
| 2 | Long-term potentiation_Homo sapiens_hsa04720 | 2.79052254 |
| 3 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.74349230 |
| 4 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.70899031 |
| 5 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.67645707 |
| 6 | Circadian entrainment_Homo sapiens_hsa04713 | 2.53849790 |
| 7 | GABAergic synapse_Homo sapiens_hsa04727 | 2.49330838 |
| 8 | Morphine addiction_Homo sapiens_hsa05032 | 2.43512633 |
| 9 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.42621330 |
| 10 | Olfactory transduction_Homo sapiens_hsa04740 | 2.31461604 |
| 11 | Taste transduction_Homo sapiens_hsa04742 | 2.28908718 |
| 12 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.21727364 |
| 13 | Insulin secretion_Homo sapiens_hsa04911 | 2.19557798 |
| 14 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.13923603 |
| 15 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.13219801 |
| 16 | Salivary secretion_Homo sapiens_hsa04970 | 2.12470603 |
| 17 | Renin secretion_Homo sapiens_hsa04924 | 2.00623352 |
| 18 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.98862363 |
| 19 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.90836664 |
| 20 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.89973501 |
| 21 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.81953560 |
| 22 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.81130373 |
| 23 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.74738851 |
| 24 | Long-term depression_Homo sapiens_hsa04730 | 1.68802796 |
| 25 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.63944359 |
| 26 | Cocaine addiction_Homo sapiens_hsa05030 | 1.58837892 |
| 27 | ABC transporters_Homo sapiens_hsa02010 | 1.58685994 |
| 28 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.58674153 |
| 29 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.50867056 |
| 30 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.49814180 |
| 31 | RNA degradation_Homo sapiens_hsa03018 | 1.48996813 |
| 32 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.48417250 |
| 33 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.47205947 |
| 34 | Phototransduction_Homo sapiens_hsa04744 | 1.47139623 |
| 35 | Basal transcription factors_Homo sapiens_hsa03022 | 1.47071037 |
| 36 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.44304221 |
| 37 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.39190236 |
| 38 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.39032597 |
| 39 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.36011958 |
| 40 | Retinol metabolism_Homo sapiens_hsa00830 | 1.35915915 |
| 41 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.35419126 |
| 42 | Homologous recombination_Homo sapiens_hsa03440 | 1.35103456 |
| 43 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.34380349 |
| 44 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.32046862 |
| 45 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.30893289 |
| 46 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.30654035 |
| 47 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.27518315 |
| 48 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.27108110 |
| 49 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.25691222 |
| 50 | Histidine metabolism_Homo sapiens_hsa00340 | 1.25489884 |
| 51 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.24193147 |
| 52 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.23554577 |
| 53 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.19768808 |
| 54 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.18513249 |
| 55 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.17939893 |
| 56 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.14260539 |
| 57 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.12383495 |
| 58 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.09218336 |
| 59 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.08756038 |
| 60 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.08047517 |
| 61 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.07312047 |
| 62 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.06975353 |
| 63 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.05649817 |
| 64 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.05507001 |
| 65 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.05301524 |
| 66 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.05259951 |
| 67 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.03311512 |
| 68 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.01033845 |
| 69 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.97017718 |
| 70 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.96996076 |
| 71 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.96879407 |
| 72 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.95643341 |
| 73 | Protein export_Homo sapiens_hsa03060 | 0.94395630 |
| 74 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.93799918 |
| 75 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.92915723 |
| 76 | Melanogenesis_Homo sapiens_hsa04916 | 0.92768632 |
| 77 | Axon guidance_Homo sapiens_hsa04360 | 0.92079170 |
| 78 | Gap junction_Homo sapiens_hsa04540 | 0.88677763 |
| 79 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.88580886 |
| 80 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.88430741 |
| 81 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.87237490 |
| 82 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.83002399 |
| 83 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.81777031 |
| 84 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.80367828 |
| 85 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.80036167 |
| 86 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.79769388 |
| 87 | Glioma_Homo sapiens_hsa05214 | 0.79071533 |
| 88 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.78211105 |
| 89 | Mineral absorption_Homo sapiens_hsa04978 | 0.77782655 |
| 90 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.76371395 |
| 91 | Circadian rhythm_Homo sapiens_hsa04710 | 0.72996374 |
| 92 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.72683746 |
| 93 | Alzheimers disease_Homo sapiens_hsa05010 | 0.70574040 |
| 94 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.70001598 |
| 95 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.69846741 |
| 96 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.68020299 |
| 97 | Bile secretion_Homo sapiens_hsa04976 | 0.67261120 |
| 98 | Lysine degradation_Homo sapiens_hsa00310 | 0.66996772 |
| 99 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.65828885 |
| 100 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.65425411 |
| 101 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.64854600 |
| 102 | Peroxisome_Homo sapiens_hsa04146 | 0.64718208 |
| 103 | Allograft rejection_Homo sapiens_hsa05330 | 0.63781134 |
| 104 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.60670217 |
| 105 | Platelet activation_Homo sapiens_hsa04611 | 0.60495302 |
| 106 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.60466345 |
| 107 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.59861001 |
| 108 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.59476588 |
| 109 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.58491814 |
| 110 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.57450160 |
| 111 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.57149727 |
| 112 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.56350152 |
| 113 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.55513962 |
| 114 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.55452820 |
| 115 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.55300656 |
| 116 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.55240374 |
| 117 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.54524237 |
| 118 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.54491482 |
| 119 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.54446005 |
| 120 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.54191155 |
| 121 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.52045666 |
| 122 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.50787982 |
| 123 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.50021088 |
| 124 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.49056815 |
| 125 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.48979425 |
| 126 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.43818560 |
| 127 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.43725355 |
| 128 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.37960268 |
| 129 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.37411962 |
| 130 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.35206303 |
| 131 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.34232217 |
| 132 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.28394756 |
| 133 | Alcoholism_Homo sapiens_hsa05034 | 0.28345464 |
| 134 | Adherens junction_Homo sapiens_hsa04520 | 0.27919709 |
| 135 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.26141724 |
| 136 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.25977942 |
| 137 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.25837745 |
| 138 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.24719015 |
| 139 | Phagosome_Homo sapiens_hsa04145 | 0.24421355 |
| 140 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.23643500 |
| 141 | Tight junction_Homo sapiens_hsa04530 | 0.20819517 |
| 142 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.19696078 |
| 143 | Endometrial cancer_Homo sapiens_hsa05213 | 0.19162989 |
| 144 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.18438553 |
| 145 | Huntingtons disease_Homo sapiens_hsa05016 | 0.18097560 |
| 146 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.18095545 |
| 147 | Prion diseases_Homo sapiens_hsa05020 | 0.17861837 |
| 148 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.17531462 |
| 149 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.15074575 |
| 150 | Endocytosis_Homo sapiens_hsa04144 | 0.13826686 |

